港股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

生物醫藥B類股

606.745

+27.3854.73%

漲家數：29

跌家數：4

平家數：1

市盈率：- -

高：611.657

開：579.115

低：567.229

收：579.360

成交量：2.07億

成交額：45.56億

市值：3,858.51億

流通市值：3,444.46億

資料載入中...

總覽新聞資訊

3月27日我武生物漲6.38%，鵬華醫藥科技股票A基金重倉該股

説説幾位基金經理變動：任相棟離開興全、鄭寧已入職易方達，天弘又挖了一位老將

港股綜述｜三大指數收漲，生物醫藥股大漲，基石藥業-B升逾20%；「詞元第一股」迅策升逾24%

老虎资讯综合

普利製藥索賠徵集中，符合要求還可加入

港股收評：恒指漲0.38% 科指漲0.35% 鋰電池板塊活躍創新藥概念股大漲

貝康醫療－Ｂ(02170)股價上升5.263%，現價港幣$2.0

阿斯达克财经

諾華製藥(NVS.US)20億美元收購Excellergy 加碼食物過敏與免疫疾病賽道

華領醫藥(02552)2025年報觀：從首迎年度盈利，探尋GKA龍頭的長期增長邏輯

康方生物(09926)出現大手買入5.9萬股，成交價$128.0，涉資755.2萬

阿斯达克财经

東曜藥業－Ｂ(01875)股價上升8.19%，現價港幣$5.68

阿斯达克财经

2025醫藥年報釋放積極信號，板塊發展邏輯或進一步夯實

康諾亞－Ｂ(02162)股價上升5.03%，現價港幣$60.55

阿斯达克财经

創新藥龍頭盈利拐點確認，板塊情緒回暖迎配置窗口

再鼎醫藥(09688)股價上升5.033%，現價港幣$14.19

阿斯达克财经

心瑋醫療－Ｂ(06609)股價上升5.125%，現價港幣$46.36

阿斯达克财经

知名藥企IPO關鍵期，被曝銷售行賄，一款藥撐起公司超99%收入

21世纪经济报道

超3700股上漲，鋰電池、創新藥集體走強，專家：A股年內或創新高

21世纪经济报道

「十億美元分子」雙核共振，亞盛醫藥-B(06855)加速全球創新價值兑現

基石藥業-B午前漲幅擴大逾20% CS2009肺癌療效數據亮眼

5分鐘，封死漲停！千億巨頭，徹底引爆！整個板塊集體飆升

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/hant/stock/BK1574/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK1574","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1574\",,,,,undefined,":{"symbol":"BK1574","market":"HK","secType":"PLATE","nameCN":"生物醫藥B類股","latestPrice":606.74475,"timestamp":1774598898612,"preClose":579.3598,"halted":0,"volume":206587090,"delay":0,"changeRate":0.047268,"floatShares":0,"shares":0,"eps":0,"marketStatus":"已收盤","change":27.384949,"latestTime":"03-27 16:00:00","open":579.1151,"high":611.6572,"low":567.22943,"amount":4555921928,"amplitude":0.076684,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1774834200000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1774575000000,1774584000000],[1774587600000,1774598400000]],"pbRate":5.137827,"peRate":-72.511291,"turnoverRate":0.007466,"increases":29,"decrements":3,"flats":1,"marketCap":385851372864,"floatMarketCap":344445595920},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1574\",,,,,undefined,":{"symbol":"BK1574","high":611.6572,"amplitude":0.076684,"preClose":579.3598,"low":567.22943,"pbRate":"5.137827","latestPrice":606.74475,"volume":206587090,"delay":0,"open":579.1151,"prevYearClose":556.26263,"prevWeekClose":560.669,"prevMonthClose":553.496,"prevQuarterClose":556.263,"fiveDayClose":560.669,"twentyDayClose":553.496,"sixtyDayClose":561.301,"secType":"PLATE","market":"HK","turnoverRate":0.007466,"peRate":-72.511291,"marketCap":385851372864,"floatMarketCap":344445595920,"timestamp":1774598898612,"nameCN":"生物醫藥B類股"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1574\",,,,undefined,":{"bkCode":"BK1574","up":29,"down":4,"flat":1},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1574\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2622841264","title":"3月27日我武生物漲6.38%，鵬華醫藥科技股票A基金重倉該股","url":"https://stock-news.laohu8.com/highlight/detail?id=2622841264","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622841264?lang=zh_tw&edition=fundamental","pubTime":"2026-03-27 16:56","pubTimestamp":1774601805,"startTime":"0","endTime":"0","summary":"证券之星消息，3月27日我武生物涨6.38%，收盘报25.5元，换手率4.14%，成交量20.06万手，成交额5.0亿元。重仓我武生物的前十大公募基金请见下表：根据2025基金年报公募基金重仓股数据，重仓该股的公募基金共14家，其中持有数量最多的公募基金为鹏华基金的鹏华医药科技股票A。鹏华医药科技股票A目前规模为17.21亿元，最新净值1.5812，较上一交易日下跌1.0%，近一年上涨37.26%。该公募基金现任基金经理为金笑非。","market":"sh","thumbnail":" http://caiji.3g.cnfol.com/colect/202603/27/20260327287849.png","type":0,"news_type":0,"thumbnails":[" http://caiji.3g.cnfol.com/colect/202603/27/20260327287849.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushiyaowen/20260327/32104596.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["300357","BK0028","BK1161","BK1515","09939","BK0239","BK1574","159938"],"gpt_icon":0},{"id":"2622849450","title":"説説幾位基金經理變動：任相棟離開興全、鄭寧已入職易方達，天弘又挖了一位老將","url":"https://stock-news.laohu8.com/highlight/detail?id=2622849450","media":"市场资讯","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622849450?lang=zh_tw&edition=fundamental","pubTime":"2026-03-27 16:24","pubTimestamp":1774599840,"startTime":"0","endTime":"0","summary":"　　春和景明，人心浮动，说说几位基金经理的变动。　　任相栋离任兴全基金官宣了，原中银基金郑宁已入职易方达，老将邓炯鹏要去天弘基金，万民远卸任一只亏损基金…　　今天，兴全基金中生代明星基金经理任相栋，官宣离职了。　　上周，任相栋名下两只基金增聘基金经理的时候，就已经传任相栋要离开的消息了。　　任相栋，离职前是兴全基金管理部副总监和国际业务部副总监，下一步是跳槽到其他公募还是奔私，还暂无消息。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/wm/2026-03-27/doc-inhsmhtx8392338.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1574","06978","BK1161"],"gpt_icon":0},{"id":"1167591035","title":"港股綜述｜三大指數收漲，生物醫藥股大漲，基石藥業-B升逾20%；「詞元第一股」迅策升逾24%","url":"https://stock-news.laohu8.com/highlight/detail?id=1167591035","media":"老虎资讯综合","labels":["AIColumn"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1167591035?lang=zh_tw&edition=fundamental","pubTime":"2026-03-27 16:10","pubTimestamp":1774599050,"startTime":"0","endTime":"0","summary":"基石药业、石药集团、昭衍新药等创新药股受临床进展与政策扶持刺激大幅拉升；“词元第一股”迅策借Token经济概念再创新高，带动信息科技咨询板块整体走强。短期建议关注医药、科技外包及智能汽车链的持续交易机会，同时留意油价波动对航空、消费链的潜在影响。","market":"fut","thumbnail":"https://static.tigerbbs.com/082208e3c37780dd55878056410ffa43","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/082208e3c37780dd55878056410ffa43"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"AIColumn","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HSI","HSTECH","BK1161","BK1574","HSCEI","BK1515","BK4588","BK4585"],"gpt_icon":0},{"id":"2622846751","title":"普利製藥索賠徵集中，符合要求還可加入","url":"https://stock-news.laohu8.com/highlight/detail?id=2622846751","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622846751?lang=zh_tw&edition=fundamental","pubTime":"2026-03-27 16:09","pubTimestamp":1774598940,"startTime":"0","endTime":"0","summary":"　　上海沪紫律师事务所刘鹏律师团队近日再次收到一批胜诉判决。此前海口市中级人民法院对投资者诉普利制药证券虚假陈述责任纠纷案件作出一审胜诉判决，公司需赔付股民损失。回溯此案，2025年3月21日，公司收到证监会的处罚决定，因财务造假极其严重触及重大违法强制退市，该公司已在2025年4月正式告别A股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/gmwq/rightscase/2026-03-27/doc-inhsmhtr9584247.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1574","BK1191","01477"],"gpt_icon":0},{"id":"2622846221","title":"港股收評：恒指漲0.38% 科指漲0.35% 鋰電池板塊活躍 創新藥概念股大漲","url":"https://stock-news.laohu8.com/highlight/detail?id=2622846221","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622846221?lang=zh_tw&edition=fundamental","pubTime":"2026-03-27 16:08","pubTimestamp":1774598880,"startTime":"0","endTime":"0","summary":"　　3月27日消息，港股三大指数集体上涨。截至收盘，恒生指数涨0.38%，报24951.88点，恒生科技指数涨0.35%，国企指数涨0.76%。盘面上，科网股涨跌不一，快手、小米涨超1%，哔哩哔哩跌超1%；创新药概念股大涨，石药集团涨超13%；锂电池板块涨幅居前，赣锋锂业涨超9%；商业航天板块跌幅居前，钧达股份跌超9%。近期创新药企业年报密集披露，龙头企业盈利能力显著提升，现金流丰沛，为长期研发投入筑牢根基。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2026-03-27/doc-inhsmhtw2154112.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["HSTECH","BK4585","MCHmain","HSI","513600","BK4588","02833","002460","BK1574","01093","HHImain","BK1161"],"gpt_icon":1},{"id":"2622846986","title":"貝康醫療－Ｂ(02170)股價上升5.263%，現價港幣$2.0","url":"https://stock-news.laohu8.com/highlight/detail?id=2622846986","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622846986?lang=zh_tw&edition=fundamental","pubTime":"2026-03-27 15:45","pubTimestamp":1774597500,"startTime":"0","endTime":"0","summary":"[上升股]贝康医疗－Ｂ(02170) 股价在下午03:45比前收市价上升5.263%，现股价为港币$2.0。至目前为止，今日最高价为$2.0，而最低价为$1.9。总成交量为9.3万股，总成交金额为港币$18.276万。","market":"hk","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180112133337750_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180112133337750_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR2603273224/aamm-all-category","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR2603273224/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["02170","BK1597","BK1574","BK1222"],"gpt_icon":0},{"id":"2622845105","title":"諾華製藥(NVS.US)20億美元收購Excellergy 加碼食物過敏與免疫疾病賽道","url":"https://stock-news.laohu8.com/highlight/detail?id=2622845105","media":"智通财经","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622845105?lang=zh_tw&edition=fundamental","pubTime":"2026-03-27 15:36","pubTimestamp":1774597007,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，诺华制药已同意以高达20亿美元的价格收购生物技术公司Excellergy Inc.，此项交易将强化其在食物过敏及其他免疫疾病治疗领域的产品组合。此次收购的核心资产是Excellergy公司研发的创新候选药物Exl-111。从行业影响来看，Excellergy的加入将使诺华制药在过敏性疾病领域拥有更具差异化的产品组合。此外，诺华制药还于去年10月宣布了其最大规模投资之一——以120亿美元收购Avidity Biosciences公司，随后又陆续达成多项针对过敏性疾病及乳腺癌药物的交易合作。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1420347.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1191","BK4578","NVS","LU0211331839.USD","LU0070302665.USD","IE00B2B36J28.USD","01477","BK4532","IE0009355771.USD","IE00BFTCPJ56.SGD","IE00BJT1NW94.SGD","BK4585","IE00BJJMRZ35.SGD","LU0320765489.SGD","LU0208291251.USD","BK4588","IE0002141913.USD","BK4007","BK1574","IE00B4R5TH58.HKD"],"gpt_icon":0},{"id":"2622438848","title":"華領醫藥(02552)2025年報觀：從首迎年度盈利，探尋GKA龍頭的長期增長邏輯","url":"https://stock-news.laohu8.com/highlight/detail?id=2622438848","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622438848?lang=zh_tw&edition=fundamental","pubTime":"2026-03-27 15:00","pubTimestamp":1774594800,"startTime":"0","endTime":"0","summary":"截至2025年末，华堂宁已通过3000多家医院、社区卫生中心、药房和线上渠道惠及超50万名患者，商业化体系的成功得到充分验证。值得关注的是，作为全球首创GKA药物的研发企业，华领医药的领跑优势不仅在于创新产品，更在于对“商业确定性”的持续构建，2025年的两大关键进展，进一步强化了其在GKA赛道的龙头地位。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1420319.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1191","BK1574","02552"],"gpt_icon":0},{"id":"2622480478","title":"康方生物(09926)出現大手買入5.9萬股，成交價$128.0，涉資755.2萬","url":"https://stock-news.laohu8.com/highlight/detail?id=2622480478","media":"阿斯达克财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622480478?lang=zh_tw&edition=fundamental","pubTime":"2026-03-27 14:54","pubTimestamp":1774594440,"startTime":"0","endTime":"0","summary":"[大手成交]康方生物(09926)在下午02:54出现大手买入，成交量为5.9万，成交价为港币$128.0，涉资755.2万。至目前为止，股价升3.395%，今日最高价为$128.0，而最低价为$117.0，总成交量为1.17千万股，总成交金额港币$14.523亿。","market":"sh","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180205145550868_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180205145550868_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAT2603276416/aamm-all-category","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAT2603276416/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["LU1961090484.USD","IE00B543WZ88.USD","LU1720050803.USD","LU0540923850.HKD","LU0348784397.USD","LU0417516571.SGD","LU0348735423.USD","BK1574","IE00B5MMRT66.SGD","LU0417516902.SGD","BK1161","LU0348767384.USD","LU0561508036.HKD","LU0348783233.USD","IE00BPRC5H50.USD","09926","LU0634319403.HKD","LU0348827113.USD","LU2399975544.HKD","LU2488822045.USD","LU0417516738.SGD","LU2778985437.USD","LU0348766576.USD","LU2476274308.USD","LU2476274720.SGD","LU0348825331.USD","LU1794554557.SGD"],"gpt_icon":0},{"id":"2622810036","title":"東曜藥業－Ｂ(01875)股價上升8.19%，現價港幣$5.68","url":"https://stock-news.laohu8.com/highlight/detail?id=2622810036","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622810036?lang=zh_tw&edition=fundamental","pubTime":"2026-03-27 14:20","pubTimestamp":1774592400,"startTime":"0","endTime":"0","summary":"[上升股]东曜药业－Ｂ(01875) 股价在下午02:20比前收市价上升8.19%，现股价为港币$5.68。至目前为止，今日最高价为$5.68，而最低价为$5.27。总成交量为217.08万股，总成交金额为港币$1.197千万。","market":"fut","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180416150419953_s.png","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180416150419953_s.png"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR2603273017/aamm-all-category","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR2603273017/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["01875","BK1574","BK1161"],"gpt_icon":0},{"id":"2622810331","title":"2025醫藥年報釋放積極信號，板塊發展邏輯或進一步夯實","url":"https://stock-news.laohu8.com/highlight/detail?id=2622810331","media":"新浪基金","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622810331?lang=zh_tw&edition=fundamental","pubTime":"2026-03-27 14:03","pubTimestamp":1774591380,"startTime":"0","endTime":"0","summary":"根据Wind数据，截至3月24日，申万医药生物行业已披露年报的公司中，超七成实现盈利，展现出一定的复苏势头。综合机构研报，在业绩兑现、研发加速、板块低估等多重驱动下，医药生物板块，尤其是创新药赛道的中长期关注价值或正持续凸显。　　据Wind数据统计，截至2026年3月24日，全市场A股的申万医药生物行业中已有169家公司披露2025年年报。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/money/fund/jjh/2026-03-27/doc-inhsmamz8429313.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1161","BK1574","09939","159938","BK1515"],"gpt_icon":0},{"id":"2622591810","title":"康諾亞－Ｂ(02162)股價上升5.03%，現價港幣$60.55","url":"https://stock-news.laohu8.com/highlight/detail?id=2622591810","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622591810?lang=zh_tw&edition=fundamental","pubTime":"2026-03-27 13:55","pubTimestamp":1774590900,"startTime":"0","endTime":"0","summary":"[上升股]康诺亚－Ｂ(02162) 股价在下午01:55比前收市价上升5.03%，现股价为港币$60.55。至目前为止，今日最高价为$60.55，而最低价为$56.35。总成交量为294.25万股，总成交金额为港币$1.747亿。","market":"fut","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20190515141041255_s.png","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20190515141041255_s.png"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR2603272939/aamm-all-category","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR2603272939/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1583","02162","BK1574","BK1587","BK1161"],"gpt_icon":0},{"id":"2622685810","title":"創新藥龍頭盈利拐點確認，板塊情緒回暖迎配置窗口","url":"https://stock-news.laohu8.com/highlight/detail?id=2622685810","media":"财闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622685810?lang=zh_tw&edition=fundamental","pubTime":"2026-03-27 13:40","pubTimestamp":1774590000,"startTime":"0","endTime":"0","summary":"截至3月27日13时18分，创新药板块强势上涨3.79%，港股创新药板块同步上涨4.82%，成交活跃度提升。核心驱动力为龙头企业业绩超预期落地，首次实现全年盈利，行业盈利拐点进一步夯实，直接带动板块情绪全面回暖。3月26日信达生物披露2025年业绩，全年总收入130.42亿元，同比增长38.4%，首次实现全年盈利，净利润8.1亿元成功扭亏。与此同时，诺诚健华、云顶新耀等多家药企同步实现扭亏，行业整体盈利拐点已全面确认。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/hk/2026-03-27/doc-inhsmamw5412822.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1574","BK1161","159992","06978"],"gpt_icon":0},{"id":"2622817666","title":"再鼎醫藥(09688)股價上升5.033%，現價港幣$14.19","url":"https://stock-news.laohu8.com/highlight/detail?id=2622817666","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622817666?lang=zh_tw&edition=fundamental","pubTime":"2026-03-27 13:30","pubTimestamp":1774589400,"startTime":"0","endTime":"0","summary":"[上升股]再鼎医药(09688) 股价在下午01:30比前收市价上升5.033%，现股价为港币$14.19。至目前为止，今日最高价为$14.19，而最低价为$13.35。总成交量为624.95万股，总成交金额为港币$8.694千万。","market":"other","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180416150419953_s.png","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180416150419953_s.png"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR2603272741/aamm-all-category","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR2603272741/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["09688","BK1161","BK1588","BK1574","LU2488822045.USD"],"gpt_icon":0},{"id":"2622817864","title":"心瑋醫療－Ｂ(06609)股價上升5.125%，現價港幣$46.36","url":"https://stock-news.laohu8.com/highlight/detail?id=2622817864","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622817864?lang=zh_tw&edition=fundamental","pubTime":"2026-03-27 13:13","pubTimestamp":1774588380,"startTime":"0","endTime":"0","summary":"[上升股]心玮医疗－Ｂ(06609) 股价在下午01:13比前收市价上升5.125%，现股价为港币$46.36。至目前为止，今日最高价为$46.36，而最低价为$44.1。总成交量为2.15万股，总成交金额为港币$97.668万。","market":"hk","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180205152549604_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180205152549604_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR2603272450/aamm-all-category","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR2603272450/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1574","BK1587","BK1100","06609"],"gpt_icon":0},{"id":"2622814754","title":"知名藥企IPO關鍵期，被曝銷售行賄，一款藥撐起公司超99%收入","url":"https://stock-news.laohu8.com/highlight/detail?id=2622814754","media":"21世纪经济报道","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622814754?lang=zh_tw&edition=fundamental","pubTime":"2026-03-27 12:25","pubTimestamp":1774585500,"startTime":"0","endTime":"0","summary":"　　医药反腐风暴下，又一拟上市企业卷入商业贿赂漩涡。　　3月24日，国家医保局通报“张某猛药品销售行贿案”，而众多涉案细节，指向药品复方黄柏液涂剂的独家生产企业，正处于赴港IPO关键期的山东汉方制药股份有限公司。2024年11月，张某猛因行贿罪和对非国家工作人员行贿罪，被判处有期徒刑一年、缓刑一年半，并处罚金2万元。汉方制药在IPO关键期遭遇行贿案冲击，再次凸显了医药企业规范经营的重要性。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/newstock/2026-03-27/doc-inhsmamz8378246.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/newstock/2026-03-27/doc-inhsmamz8378246.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1191","01477","BK1574"],"gpt_icon":0},{"id":"2622781451","title":"超3700股上漲，鋰電池、創新藥集體走強，專家：A股年內或創新高","url":"https://stock-news.laohu8.com/highlight/detail?id=2622781451","media":"21世纪经济报道","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622781451?lang=zh_tw&edition=fundamental","pubTime":"2026-03-27 11:53","pubTimestamp":1774583580,"startTime":"0","endTime":"0","summary":"炒股就看金麒麟分析师研报，权威，专业，及时，全面，助您挖掘潜力主题机会！　　记者丨张嘉钰 林健民。　　3月27日，A股早盘低开高走，截至午盘，四大指数均翻红，沪指涨0.26%，深成指涨0.93%，创业板指涨0.83%，科创综指涨1.08%。沪深两市半日成交额1.14万亿，全市场超3700只个股上涨。　　从板块来看，创新药概念集体飙升，A股创新药板块大涨3%，美诺华（维权）开盘后五分钟封死涨停板，实现6天5板。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/wm/2026-03-27/doc-inhsmamt9565246.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/wm/2026-03-27/doc-inhsmamt9565246.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4588","399300","BK4585","LIT","BK1574","06978","159992","BK1161","159982"],"gpt_icon":0},{"id":"2622811719","title":"「十億美元分子」雙核共振，亞盛醫藥-B(06855)加速全球創新價值兑現","url":"https://stock-news.laohu8.com/highlight/detail?id=2622811719","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622811719?lang=zh_tw&edition=fundamental","pubTime":"2026-03-27 11:49","pubTimestamp":1774583348,"startTime":"0","endTime":"0","summary":"3月26日，亚盛医药-B2025年年度业绩正式出炉。“十亿美元分子”双核共振，夯实创新与全球化根基作为一家已经进入商业化加速阶段的创新药企业，亚盛医药在2025年最核心的价值研判锚点在于：不同于此前依靠耐立克“单点突破”，公司现阶段的全球商业化已步入“十亿美元分子”双核共振关键期。作为亚盛医药的第二款商业化产品，利生妥报告期内获批上市，为公司“十亿美元分子”双核共振奠定了重要基础，也成为公司业绩加速增长的关键一极。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1420256.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","06855","BK4139","BK1574","AAPG"],"gpt_icon":0},{"id":"2622446811","title":"基石藥業-B午前漲幅擴大逾20% CS2009肺癌療效數據亮眼","url":"https://stock-news.laohu8.com/highlight/detail?id=2622446811","media":"新浪港股","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622446811?lang=zh_tw&edition=fundamental","pubTime":"2026-03-27 11:41","pubTimestamp":1774582860,"startTime":"0","endTime":"0","summary":"　　基石药业-B午前涨幅扩大逾20%，截至发稿，股价上涨20.29%，现报8.30港元，成交额3.90亿港元。　　基石药业公布，公司自主研发的PD-1/VEGF/CTLA-4三特异性抗体CS2009的最新临床进展。CS2009单药针对肺癌的I/II期初步疗效数据积极。　　基于以上结果，基石药业计划于2026年底前启动CS2009首批III期全球多中心临床试验，重点布局NSCLC、结直肠癌、小细胞肺癌等适应症。更多CS2009的I期和II期临床研究数据预计将于2026年在美国临床肿瘤学会年会和/或欧洲肿瘤内科学会年会上公布。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2026-03-27/doc-inhskwcy5489184.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["02616","BK1161","BK1574"],"gpt_icon":0},{"id":"2622581161","title":"5分鐘，封死漲停！千億巨頭，徹底引爆！整個板塊集體飆升","url":"https://stock-news.laohu8.com/highlight/detail?id=2622581161","media":"券商中国","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622581161?lang=zh_tw&edition=fundamental","pubTime":"2026-03-27 11:31","pubTimestamp":1774582260,"startTime":"0","endTime":"0","summary":"炒股就看金麒麟分析师研报，权威，专业，及时，全面，助您挖掘潜力主题机会！　　昨天是锂电池，今天轮到创新药。3月27日早盘，创新药概念持续走高，美诺华（维权）开盘后五分钟封死涨停板，科拓生物20CM涨停，万邦德、联环药业、双鹭药业涨停，热景生物、益诺思涨超10%。A股创新药板块大涨3%。　　港股方面亦有反应，信达生物首次全面盈利，重磅战略合作加速兑现管线全球价值，该股一度大涨超7%。彻底引爆整个生物医药板块。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/roll/2026-03-27/doc-inhskwcy5485109.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU2097828557.USD","LU2488822045.USD","HK0000165453.HKD","LU0455707207.USD","06978","BK1574","LU1969619763.USD","LU2097828474.EUR","LU2242644610.SGD","LU2097828805.USD","BK1589","LU2097828631.EUR","LU2328871848.SGD","BK1161","BK1583","01801","LU0502904849.HKD","LU2097828714.EUR"],"gpt_icon":0}],"pageSize":20,"totalPage":16,"pageCount":1,"totalSize":320,"code":"91000000","status":"200"}]}}